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INTRODUCTION 
Dengue is the most rapidly spreading mosquito-borne 
viral disease in the world. In the last 50 years, incidence 
has increased 30-fold with increasing geographic ex-
pansion to new countries and in the present decade, 
from urban to rural settings.[1] It has been recently 
estimated that 390 millions dengue infections occur 
every year (95% credible interval 284- 528 million), of 
which 96 millions (67-136 millions) manifest clinically 
with any severity of disease.[2,3] 
In view of the high mortality rate and to reduce the 
disease burden, it is imperative to have a rapid and 
sensitive laboratory assay for early detection of the 
disease. Though, there are several laboratory methods 
available to diagnose dengue infection such as viral 
isolation, detection of RNA, antigen and antibody as-
says, haemagglutination inhibition (HI), plaque reduc-
tion neutralization test (PRNT), most of these are time-
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consuming costly methods and need a specialized la-
boratory with well-trained personnel which may not be 
widely available in many hospital settings.[1] 
During last few years, non-structural 1 (NS1) antigen 
has emerged as a useful biomarker for early diagnosis 
of dengue virus (DENV) infection. Seven, non overlap-
ping, virus NS proteins have been identified and 
mapped to the viral RNA by limited amino and carboxy 
terminal amino acid sequencing. Encoded 3' to the 
structural protein-coding region and following the E 
protein are NS1, NS2a, NS2b, NS3, NS4a, NS4b and 
NS5.[4,5] 
NS1 is a highly conserved glycoprotein with molecular 
weight of ~48,000 kDa for all the serotypes and pro-
duced in both cell membrane-associated and secreted 
forms. It is essential for virus viability or replication, but 
has no biological activity and precise function has not 
yet been assigned to it. It stimulates a strong humoral 
response.NS1 antigen is detectable in blood from first 
day after the onset of fever up to day 9 and is also de-
tectable in the presence of IgM antibodies and when 
viral RNA is negative by RT-PCR.[4-6] 
Currently, NS1 antigen capture enzyme linked immuno-
sorbent assay (ELISA) and rapid NS1 antigen commer-
cial kits for detection of NS1 antigen are available. Its 
use has been suggested for early diagnosis of dengue 
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infection after the onset of fever.[1] Considering this, 
the present study was conducted to evaluate the po-
tential use of the dengue NS1 antigen ELISA test to im-
prove dengue laboratory diagnosis and to compare it 
with the current antibody techniques available in our 
laboratory. 
MATERIAL AND METHODS 
Study design: An observational study 
Ethics approval: Approval was obtained from the intui-
tional ethical committee. 
Study location: The present study was carried out in 
department of Microbiology at a tertiary care hospital, 
in central India which is a sentinel surveillance site un-
der National Vector Born Disease Control Programme 
(NVBDCP). 
Study period: It was carried out from July 2014 to June 
2016.  
Sample size: Total 2106 serum samples from suspected 
dengue cases were included in this study. 
Inclusion criteria: Study group consisted of clinically 
suspected cases of dengue infection, in the age group 
of 0-80 years and of both the sexes, admitted in the 
hospital as well as those who attended outpatient de-
partment. 
Methodology: Detailed history was obtained from each 
patient. 2ml of blood samples were collected aseptical-
ly and serum was separated as per the standard guide-
lines.[7,8] Specimens were stored at 2 – 8°C till pro-
cessing. Repeated freezing and thawing was avoided. 
The serum samples were subjected to following tests 
for the diagnosis of dengue infection - 
Dengue NS1 antigen detection with ELISA 
Dengue IgM antibody detection with ELISA 
Dengue NS1 antigen MICROLISA kit was provided by J. 
Mitra and Co. Pvt. Ltd. India. NIV DEN IgM Capture ELI-
SA (MAC ELISA) kit was provided by NIV, Pune, India. 
Tests were performed as per manufacturer’s instruc-
tions only [9,10]. 
Dengue NS1 antigen MICROLISA is a solid phase ELISA 
based on the direct sandwich principle. The microwells 
are coated with anti- dengue NS1 antibodies with high 
reactivity for dengue NS1 antigen. The samples were 
added in the wells followed by addition of enzyme con-
jugate. A sandwich complex was formed in the well 
wherein dengue NS1 was “trapped” or “sandwiched” 
between the antibody and antibody HRPO conjugate. 
Unbound conjugate was  then washed off with wash 
buffer. Addition of the substrate buffer and chromo-
gen, was followed by addition of stop solution and was 
read at 450 nm spectrophotometrically within 10 
minutes after termination of reaction. Cut off values 
and dengue NS1 antigen units were calculated. 
If the dengue NS1 antigen units were < 9 then the sam-
ple was interpreted as negative. If the dengue NS1 anti-
gen units were in between 9 - 11 then the sample was 
interpreted as equivocal and if the dengue NS1 antigen 
units were > 11 then the sample was interpreted as 
positive for dengue NS1 antigen. 
Dengue MAC ELISA is based upon the principle that IgM 
antibodies in the patient’s serum are captured by anti-
human IgM coated on to the solid surface. Dengue anti-
gen, which was added in next step, binded to captured 
human IgM in the sample. Unbound antigen was re-
moved during the washing step. In the subsequent step 
biotinylated flavivirus anti dengue monoclonal antibod-
ies were added followed by Avidin –HRP. Subsequently, 
chromogenic substrate (YMB/H2O2) was added, the 
reaction was stopped by 1N H2SO4. The intensity of 
color/ optical density (OD) was measured at 450 nm 
within 10 minutes after termination of reaction.  
If OD value of sample tested was less than OD value of 
negative control by factor 2.0, sample was considered 
as negative. If OD value of sample tested exceeded OD 
of negative control by factor 3.0, sample was consid-
ered as positive. If OD value for sample tested exceed-
ed OD of negative control by a factor 2.0 but was less 
than OD of negative control by factor of 3.0, the sample 
was considered as equivocal. 
Statistical analysis: Data was analysed using statistical 
package for social sciences version 20 (SPSS V 20.0). 
Sensitivity, specificity, positive predictive value (PPV), 
negative predictive value (NPV) and % of accordance 
(agreement) were calculated. Relationship between 
nonparametric discreet observations was analysed by 
non parametric Chi square test. Significance value of 
less than 0.05 (p < 0.05) was considered for statistical 
tests. 
RESULTS 
Total 2106 serum samples from suspected cases were 
tested for NS1 antigen and IgM antibody for dengue by 
ELISA. Out of 2106 dengue suspected cases, 765 
(36.32%) were positive for NS1 antigen and 857 
(40.69%) were positive for dengue IgM antibody (Table 
1). Results of NS1 ELISA were compared with MAC ELI-
SA. Sensitivity, specificity, PPV, NPV were found to be 
67.06%, 74.35%, 59.86% and 79.82% respectively. Per-
centage of accordance (agreement) was found to be 
71.7% (Table 2). 
NS1 antigen was detectable in patient sera from day 1 
onwards and dengue IgM antibody was detected from 
day 3 onwards and it gradually increased in positivity 
towards the end of the acute illness phase of the dis-
ease (Table 3). Out of 765 NS1 antigen positive sam-
ples, 562 (73.46%) were from acute phase (≤ 5 days) of 
illness and 203 (26.54%) were from convalescent phase 
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(≥ 6 days) of illness. Out of 857 MAC ELISA positive 
samples, 312 (36.41%) were from acute phase of illness 
and 545 (63.59%) were from early convalescent phase 
of illness (Table 4). 
Comparison of detection rates of NS1 ELISA and MAC 
ELISA versus combined tests (NS1+ MAC ELISA) was 
also done. Combination of the two tests detected 1109 
positive samples, which were 344 samples more than 
NS1 ELISA and 252 samples more than MAC ELISA 
(Table 5, 6). 
Table 1. Positivity of dengue by NS1 ELISA and MAC 
ELISA
 
Table 2. Comparison of NS1 ELISA and MAC ELISA
 
Table 3. Positive test results by day of symptoms in 
NS1 ELISA and MAC ELISA
 
  NS1 ELISA (%) MAC ELISA (%) 
Positive  765 (36.32)  857 (40.69) 
Negative 1341 (63.68) 1249 (59.31) 
Total 2106 2106 
MAC 
ELISA 
NS1 ELISA 
Total 
Positive Negative 
Positive 513 344 857 
Negative 252 997 1249 
Total 765 1341 2106 
Days No. of 
sera 
tested 
No. of NS1 
ELISA Positive 
(%) 
No. of MAC 
ELISA Posi-
tive (%) 
Day 1 103  51 (49.51) 00 
Day 2 127  62 (48.82) 00 
Day 3 278 128 (46.04)  52 (18.71) 
Day 4 332 148 (44.58)  93 (28.01) 
Day 5 484 173 (35.74) 167 (34.50) 
Day 6 341 114 (33.43) 197 (57.77) 
Day 7 141 43 (30.49) 112 (79.43) 
Day 8 106 30 (28.30)  89 (83.96) 
Day 9 83 16 (19.27)  71 (85.54) 
Day 10 53 00  39 (73.58) 
Day 11 31 00  22 (70.97) 
Day ≥ 12 27 00 15 (55.56) 
Total 2106 765 857 
Table 4. Positivity rate and time of detection in NS1 
ELISA and MAC ELISA
 
Table 5. Comparative detection rates of NS1 ELISA 
versus combined tests (NS1+ IgM ELISA)
 
Table 6. Comparative detection rates of MAC ELISA 
versus combined tests (NS1+ IgM ELISA)
 
DISCUSSION 
Dengue fever is an acute systemic viral disease that has 
established itself globally in both endemic and epidem-
ic transmission cycles in tropical and subtropical re-
gions of the world and it represents a significant eco-
nomic and disease burden.[1] Accurate and timely diag-
nosis of DENV infection remains a problem, especially 
in resource limited countries. It is acknowledged that 
the management of dengue fever is conservative; nev-
ertheless, strict monitoring of clinical condition and 
hematological parameters is required to prevent com-
plications, which makes early diagnosis pertinent.[1] 
Early diagnosis is also vital for exclusion, as dengue 
fever in most of the cases is clinically indistinguishable 
from other febrile illnesses prevailing in “dengue sea-
son”. Furthermore, early diagnosis plays a crucial role 
in forecasting a timely warning of an epidemic and in 
undertaking effective vector control measures. 
In the present study, total 2106 serum samples from 
suspected dengue cases were tested for detection of  
NS1 antigen and IgM antibody by ELISA. Out of 2106 
dengue suspected cases, 765 (36.32%) were positive 
for dengue NS1 antigen and 857 (40.69%) were positive 
for dengue IgM antibody.  Our findings are in accord-
Day post 
onset 
illness 
No. of NS1 ELISA 
Positive (%) 
No. of MAC ELISA 
Positive (%) 
≤ 5 days 562 (73.46) 312 (36.41) 
≥ 6 days 203 (26.54) 545 (63.59) 
Total 765 857 
NS1 ELISA 
Test  
Results 
Combined Test Results  
(NS1+ IgM ELISA) 
Positive Negative Total 
Positive 765 00 765 
Negative 344 997 1341 
Total 1109 997 2106 
MAC ELI-
SA Test 
Results 
Combined Test Results  
(NS1+ IgM ELISA) 
Positive Negative Total 
Positive 857 00 857 
Negative 252 997 1249 
Total 1109 997 2106 
Rajani P. Tore et al.   NS1 Antigen Detection by ELISA in Early Laboratory Diagnosis of Dengue Infection. 
Int. j. clin. biomed. res. 2018;4(1):5-10. 
 8 
 
ance with Sahu SK et al who reported seropositivity of 
36.03% by NS1 ELISA.[11] Ukey PM et al and Karoli R et 
al reported  positivity of 31.3% and 39% respectively by 
MAC ELISA.[12,13] However, higher positive detection 
rates of 80.9% and 47.9% of NS1 ELISA and MAC ELISA 
respectively were observed by Anand AM et al.[6] The 
variability in detection rate might be because of varia-
tions in inclusion criteria of the study, method of esti-
mation and prevalence of dengue virus in that particu-
lar region. 
In the present study, we compared the results of NS1 
ELISA with MAC ELISA. Sensitivity, specificity, PPV, NPV 
were found to be 67.06%, 74.35%, 59.86% and 79.82% 
respectively. Percentage of accordance (agreement) 
was found to be 71.7% (Table 2). There are several re-
ports in literature assessing the usefulness of different 
NS1 ELISA for diagnosis of dengue infection and sensi-
tivity of NS1 ELISA has been reported from 32.2%- 
95.9%.[6, 14-16] 
We were able to detect NS1 antigen in patient’s sera 
from day 1 onwards and upto day 9 of post onset of 
illness. Dengue IgM antibody was detected from day 3 
onwards and gradual increase in positivity was ob-
served towards the end of the acute illness phase of 
the disease (Table 3). Our findings are in accordance 
with Chakravarti A et al who reported positive results 
on patients during the first 2 days of symptoms by NS1 
ELISA and dengue IgM antibodies were detected by the 
third day of symptoms.[17] Anand AM et al also ob-
served NS1 antigen positivity as early as on day 1 of 
days post onset of illness (DPO) and it was detectable 
upto day twelve.[6] The NS1 assay has a distinct ad-
vantage of being able to detect dengue antigen during 
the first 2 days of symptoms. For patients with fever 
less than 2 days in duration, the addition of the dengue 
NS1 antigen assay may improve the diagnostic arsenal 
of the clinicians. 
In the present study, out of 765 NS1 antigen positive 
samples, 562 (73.46%) were positive in acute phase of 
illness and 203 (26.54%) were positive in convalescent 
phase of illness. This dropped off of 46.92% in NS1 anti-
gen detection in acute phase and convalescent phase 
sera is statistically highly significant (p < 0.00001). Out 
of 857 MAC ELISA positive samples, 312 (36.40%) were 
positive during acute phase of illness and 545 (63.60%) 
were positive during early convalescent phase illness. 
This increase of 27.2% in IgM antibody detection in 
acute phase and convalescent phase sera is statistically 
highly significant (p < 0.00001). Similar findings have 
been reported in previous studies where NS1 antigen 
was though found to be circulating up to day 9 of ill-
ness; the level of NS1 antigen decreased significantly 
after the acute phase.[18,19] The sensitivity of MAC 
ELISA was found to be inadequate before the fifth day 
of symptoms  by Xu H et al.[20] 
The reason for differences in positivity rates of differ-
ent tests can be attributed to difference in physiological 
mechanisms guiding positivity of dengue virus. NS1 
antigen circulates uniformly in all serotypes of dengue 
virus and it circulates at high level during the first few 
days of illness.[21] NS1 antigen levels varies from 0.04 - 
2 µg/ml in acute-phase serum samples, to only  
0.04 µg/ml or even less in convalescent phase serum.
[22] Decreased levels of NS1 after 4 days of illness can 
be because of formation of immune complexes; due to 
which the target epitopes are not accessible to mono-
clonal antibodies.[23-24] However, efforts to dissociate 
immune complexes have shown to enhance the sensi-
tivity of NS1 antigen detection ELISA.[25] 
Dengue IgM antibodies are detectable in 50% of pa-
tients by 3-5 days after onset of illness, increasing to 
80% by day 5 and 99% by day 10. Dengue IgM antibody 
levels peak about two weeks after the onset of symp-
toms and then decline generally to undetectable levels 
over 2–3 months.[1] This explains significant increase in 
IgM antibody detection in convalescent phase sera 
compared to acute phase sera. 
In the present study, we compared detection rates of 
NS1 ELISA and MAC ELISA versus combined tests (NS1 + 
MAC ELISA). Combination of the two tests (NS1 + MAC 
ELISA) detected 1109 positive samples, which were 344 
samples more than NS1 ELISA and 252 samples more 
than MAC ELISA. This resulted in raise up in the positivi-
ty rate to 52.66% as against to independent positivity 
rate of 36.32% of NS1 ELISA and 40.69% of MAC ELISA 
(Table 5, 6). Combination of two tests also increased 
the sensitivity to 77.28% as opposed to the sensitivity 
of 67.05% of NS1 ELISA only (Table 2, 6). 
Similar findings have been reported in a study by Datta 
and Wattal, the independent positivity of NS1 assay 
and MAC-ELISA were 23.3% and 39.1% respectively 
which increased to 53.3% when both the tests were 
used in combination.[26] In another study, overall de-
tection rate of cases increased to 65.38% by combina-
tion of two ELISAs as compared to 25.59% and 17.3% 
by NS1 antigen ELISA and MAC ELISA alone respective-
ly.[27] 
The IgM capture ELISA is most commonly used in India 
due to its low cost, ease of handling and non-
requirement of sophisticated equipment.[28] However, 
time to IgM production varies considerably among pa-
tients. Some patients have detectable IgM by the third 
day of symptoms, others do not develop detectable 
IgM until the eighth day of symptoms. Here it is im-
portant to understand that, NS1 antigen detection as-
say has an advantage of detecting infection very early, 
however it disappears early also and is of little use in 
the early convalescence phase when IgM antibody is 
useful. Since it is also difficult to judge accurately which 
post infection day the sample is being tested, it is ideal 
to use both assays even though it would double the 
cost, it significantly adds to detection rate especially in 
Rajani P. Tore et al.   NS1 Antigen Detection by ELISA in Early Laboratory Diagnosis of Dengue Infection. 
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acute phase of illness. 
CONCLUSION 
With the widespread geographic expansion of dengue 
fever along with the increasing number and severity of 
reported cases, the use of NS1 antigen detection could 
allow clinical diagnostic laboratories in early identifica-
tion of dengue virus infections, providing with enough 
time to optimise patient management, reducing the 
time between detection of the first cases and the noti-
fication of public health authorities, including vector 
control teams. It would be safe to say that ELISAs based 
on a single biomarker, NS1 antigen or IgM antibody 
have limitations when such tests are used individually. 
The findings in present study, in general, substantiating 
the findings as reported in earlier studies and re-affirm 
the use of NS1 antigen and IgM antibody detection as 
complementary diagnostic tests in suspected cases of 
dengue infection. 
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